Related Experiment Video
Updated: Nov 19, 2025

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
The p53/miR-145a Axis Promotes Cellular Senescence and Inhibits Osteogenic Differentiation by Targeting Cbfb in
Chao Xia1, Tianyuan Jiang1, Yonghui Wang1
1Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Abstract:
The osteogenic differentiation capacity of senescent bone marrow mesenchymal stem cells (MSCs) is reduced. p53 not only regulates cellular senescence but also functions as a negative regulator in bone formation. However, the role of p53 in MSCs senescence and differentiation has not been extensively explored. In the present study, we investigated the molecular mechanism of p53 in MSCs senescence and osteogenic differentiation. We found that p53 was upregulated during cellular senescence and osteogenic differentiation of MSCs respectively induced by H2O2 and BMP9. Similarly, the expression of p53-induced miR-145a was increased significantly. Furthermore, Overexpression of miR-145a in MSCs promoted cellular senescence and inhibited osteogenic differentiation. Then, we identified that p53-induced miR-145a inhibited osteogenic differentiation by targeting core binding factor beta (Cbfb), and the restoration of Cbfb expression rescued the inhibitory effects of miRNA-145a. In summary, our results indicate that p53/miR-145a axis exert its functions both in promoting senescence and inhibiting osteogenesis of MSCs, and the novel p53/miR-145a/Cbfb axis in osteogenic differentiation of MSCs may represent new targets in the treatment of osteoporosis.
Insights
The p53 protein promotes cellular senescence and inhibits bone formation in mesenchymal stem cells (MSCs) by upregulating miR-145a, which targets Cbfb. This p53/miR-145a/Cbfb pathway offers potential therapeutic targets for osteoporosis.
Area of Science:
- Biomedical Science
- Stem Cell Biology
- Molecular Biology
Background:
- Senescent bone marrow mesenchymal stem cells (MSCs) exhibit impaired osteogenic differentiation.
- p53 is a known regulator of cellular senescence and a negative factor in bone formation.
- The precise role of p53 in MSC senescence and differentiation requires further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms underlying p53's function in MSC senescence and osteogenic differentiation.
- To explore the relationship between p53, miR-145a, and core binding factor beta (Cbfb) in MSCs.
Main Methods:
- Induction of MSC senescence and osteogenic differentiation using H2O2 and BMP9, respectively.
- Analysis of p53 and miR-145a expression levels.
- Overexpression of miR-145a in MSCs.
- Identification of Cbfb as a target of miR-145a.
- Restoration of Cbfb expression to assess rescue effects.
Main Results:
- p53 expression was upregulated during both MSC senescence and osteogenic differentiation.
- miR-145a expression was significantly increased, induced by p53.
- Overexpression of miR-145a promoted MSC senescence and inhibited osteogenic differentiation.
- p53-induced miR-145a inhibited osteogenic differentiation by targeting Cbfb.
- Restoring Cbfb expression reversed the inhibitory effects of miR-145a.
Conclusions:
- The p53/miR-145a axis promotes MSC senescence and inhibits osteogenesis.
- The newly identified p53/miR-145a/Cbfb axis is crucial for osteogenic differentiation.
- This axis presents potential therapeutic targets for treating osteoporosis.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:18Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Mesenchymal Stem Cells
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Replicative Cell Senescence